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Mitochondrial dysfunction underlies a large number of acute or progressive diseases, as well as aging.
However, proposed therapies for mitochondrial mutations suffer from poor transformation of mitochondria
with exogenous DNA, or lack of functionality of the transferred nucleic acid within the organelle. We show
that a transfer RNA import complex (RIC) from the parasitic protozoon Leishmania tropica rapidly and effi-
ciently delivered signal-tagged antisense (STAS) RNA or DNA to mitochondria of cultured human cells.
STAS-induced specific degradation of the targeted mitochondrial mRNA, with downstream effects on respir-
ation. These results reveal the existence of a novel small RNA-mediated mRNA degradation pathway in mam-
malian mitochondria, and suggest that RIC-mediated delivery could be used to target therapeutic RNAs to the
organelle within intact cells.
INTRODUCTION
The critical role of mitochondria in the etiology of a variety of
inherited and complex disorders, and of aging, is well estab-
lished (1–5). Point mutations and deletions of mitochondrial
DNA (mtDNA) cause acute or progressive encephalomyopa-
thies for which therapies have been proposed but not proved
(6). At the same time, genetic analysis of mitochondrial repli-
cation and gene expression is hampered by the lack of an effi-
cient gene transduction system.
The major problem is that mammalian mitochondria, with
their double membrane envelope, are resistant to transfection
with DNA by conventional techniques. Human mitochondria
have been reported to be naturally competent (7), but the
nature of this competence is unknown, and we have not
observed any significant unassisted uptake of RNA into
human mitochondria in vitro (see in what follows). DNA
was introduced into isolated mitochondria by electroporation
(8), but in the absence of a demonstration of its efficacy on
intracellular mitochondria, the genetic or therapeutic potential
of electroporation is limited. DNA conjugated to a mitochon-
drial signal peptide was imported via protein import channels
into isolated mitochondria (9), but there are no reports of the
effects of peptide-DNA conjugate on mitochondria within
intact cells. Peptide nucleic acids (PNAs) coupled to a lipophi-
lic cation were taken up into the mitochondria of human cells;
although PNA inhibited mutant DNA replication in vitro, it
was without effect in intracellular mitochondria (10). Alloto-
pic expression of a modified yeast tRNA gene in the nucleus
resulted in partial correction of the respiratory defects of
cells containing a mitochondrial tRNALys mutation (11);
since in this case biological activity depends upon the
import into the mitochondria of tRNA of a single specificity
(for lysine), its application is likely to be limited to only a
few diseases affected by this mutation. For therapeutic appli-
cation, high efficiency transfer, biological activity and
general applicability are desirable attributes of any nucleic
acid delivery system.
An alternative approach was suggested by our observation
that a purified RNA Import Complex (RIC; 12) from the pro-
tozoal parasite Leishmania tropica is taken up and targeted in
a biologically active form to mitochondria of primary and
cultured mammalian cells through a caveolin-1-dependent
(i.e. endocytotic) pathway (13). Mitochondrion-localized
RIC induced import of several endogenous cytosolic tRNAs,
leading to correction of the respiration defect in intracellular
mitochondria with the MERRF (Myoclonic epilepsy with
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Ragged Red Fibers) mutation in the mitochondrial tRNALys
gene (13,14). Although RIC treatment would be useful in
many diseases caused by different mitochondrial tRNA
mutations [e.g. late onset Alzheimer’s disease (tRNAGln) or
Maternally Inherited Diabetes and Deafness (tRNALeu)], it is
not applicable to mutations or deletions in protein-coding
genes.
RIC contains eight nucleus- and three mitochondrion-
encoded subunits, six of which are essential for import activity
(15).Through its largest subunit RIC1, the complex binds with
nanomolar affinity to cognate tRNAs and to an oligoribonu-
cleotide derived from the D arm of Leishmania tRNATyr
(GUA) and containing an import signal (16). In this report,
we have examined whether these two properties of RIC, i.e.
intracellular targeting and high affinity for RNA, can be com-
bined to achieve mitochondrial delivery of functional RNA.
RESULTS
Targeting strategy
To examine the ability of RIC to deliver functional RNAs,
several RNA oligomers (Signal-Tagged AntiSense or STAS)
were synthesized, each of length 40 nt, with (i) an import
signal corresponding to the D arm hairpin of Leishmania
tRNATyr (16) at its 5’ end, followed by (ii) a gene-specific
antisense sequence complementary to the 5’-terminal region
(spanning the first 5–6 codons) of a mitochondrial mRNA
(Fig. 1A, Supplementary Material, Fig. S1). The tagged
RNA would bind RIC through the import signal and be
ferried to mitochondria, the ultimate destination of RIC in
its internalization pathway (13). Within the organelle, the anti-
sense moiety would bind to the initiation region of the target
mRNA, leading to translation inhibition through steric exclu-
sion of ribosomes and/or initiation factors. In order to test
the generality of the approach, mitochondrion-encoded sub-
units of various respiratory complexes were targeted: ND1
of complex I (NADH dehydrogenase); CYB of complex III
(ubiquinol–cytochrome c reductase); COI and COII of
complex IV (cytochrome c oxidase); and A6 of complex V
(F1Fo-ATP synthase).
Uptake of signal-tagged RNAs by isolated
and intracellular mitochondria
Initially, we checked the suitability of STAS RNAs as import
substrates of RIC. Isolated mitochondria from HepG2 (human
cell line) were pre-incubated with purified RIC to make them
import-competent, as shown previously (14). The import of
radiolabeled RNAs into the RIC-reconstituted mitochondria
was assayed by RNase protection. In the presence of RIC,
all the STAS RNAs tested were imported. Import was depen-
dent on RIC, as well as on the signal tag, since AS(ND1), tar-
geted to the ND1 mRNA but lacking the D arm hairpin, was
not imported (Fig. 1B).
Cross-linking of RIC with the D arm hairpin does not affect
uptake and mitochondrial targeting of the complex but inhibits
import of the covalently bound RNA (13). Thus the two func-
tions of RIC—targeting and import—function independently,
suggesting the possibility of using RIC as a carrier for
mitochondrial delivery of exogenous signal-tagged import
substrates. To examine the uptake of these RNAs by intact
cells, Alexa Fluor 488-labeled untagged or tagged STAS
RNAs were pre-incubated with purified RIC and the noncova-
lent RNA-protein complex administered to monolayers of the
hepatocarcinoma cell line HepG2. Mitochondrial localization
in live cells was monitored by staining with the marker dye
MitoTracker Deep Red 633. After 1 h of incubation, STAS
RNA targeting the mRNA encoding the ND1 subunit of respir-
atory complex I [STAS(ND1)] was detected as discrete spots
on the cell surface. The size, shape and distribution of these
regions of local RNA concentration are similar to the discrete
spots of RIC previously detected at early times on the same
cells or in caveolin-1 downregulated HepG2 (13), and presum-
ably represent the receptor-bound RNA–RIC complex. Intern-
alization and mitochondrial localization of the RNA was
evident by 3 h. By 24 h, the RNA was localized in most of
the mitochondria in 85% of the treated cells (Fig. 1D,F).
There was no uptake of AS(ND1), or of STAS(ND1) in the
absence of RIC, but the signal tag alone (D) was taken up nor-
mally, as expected (Fig. 1E). These experiments illustrate the
rapid and quantitative uptake and targeting of signal-tagged
RNAs mediated by RIC.
The ability of this system to transport and target signal-
tagged DNA oligonucleotides was also examined. For this
purpose, an RNA–DNA chimera was prepared, containing
the D arm RNA hairpin at the 50 end covalently linked to
the ND1 antisense (DNA) sequence. The intact chimera was
efficiently imported into isolated mitochondria, and was
recovered from the mitochondrial fraction of treated cells
(Fig. 1C). The imported species was sensitive to both DNase
and RNase; RNase treatment resulted in the removal of the
hairpin from the DNA, as expected (Fig. 1C). A small fraction
of the internalized chimera was in the post-mitochondrial frac-
tion, i.e. soluble, vesicular or ribosome-bound form (Fig. 1C).
Specific degradation of target mRNAs induced by STAS
To check the effect of STAS on mitochondrial mRNAs, north-
ern blots from STAS-treated cells were analyzed. More than
80% reduction of the targeted mRNA level was observed
with different STAS RNAs (Fig. 2A, Supplementary Material,
Table S1). Downregulation was specific for the target. For
example, the level of ND1 mRNA was unaffected in the pre-
sence of STAS(COI), and vice versa, while COII mRNA was
unaltered in STAS(CYB)-targeted mitochondria (Fig. 2A).
Cytosolic mRNAs such as actin were not altered in STAS-
treated cells (Fig. 2B). These experiments show the existence
of a degradation mechanism that recognizes targeted double-
stranded RNA regions on mitochondrial mRNAs.
Although targeting was mRNA-specific, the presence of a
single base insertion [in STAS(ND1)] or 1–3 mismatches
with the target [STAS(ND1-1,2 and 3; Fig. 1A] did not sub-
stantially affect downregulation (Fig. 2B). The tolerance of
targeting to multiple mismatches within the duplex is probably
due to the high GC content and enhanced stability of the
RNA:RNA helices.
STAS RNAs targeting the 50 terminus (starting at position 1
of the mRNA), the stop codon (position 943) and internal
position 324 were effective, whereas one targeting position
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646 was not (Fig. 2C); degradation could be influenced by
structural features of the mRNA denying or facilitating
access to the antisense probe.
In addition to RNA, chimeras of single-stranded DNA oli-
gonucleotides covalently attached to D arm RNA, were
taken up into isolated as well as cellular mitochondria
(Fig. 1C), and induced degradation of the target mRNA
(Fig. 2C). This implies that the degradation mechanism recog-
nizes both RNA:RNA duplexes and RNA:DNA hybrids.
Time course experiments were performed to compare the
uptake of STAS with the degradation of the target mRNA
Figure 1. Uptake of signal-tagged antisense RNA (STAS) by mammalian cells
and tissues. (A) Molecular design of STAS. Each STAS molecule is a chimera
of a 50 import signal (the D arm hairpin of Leishmania tRNATyr(GUA); blue)
and a 30 RNA sequence (red) complementary to the 50-translation initiation
region of the target mRNA. For illustration, targeting of RNA 13, encoding
the NADH dehydrogenase subunit 1 (ND1) is shown; other targeting events
are shown in Supplementary Material, Fig. S1. Anti-ND1 sequences with
0–3 mismatches with the target (green) are shown. (B) Import of STAS
RNAs targeting various mt mRNAs into HepG2 mitochondria. Cells were cul-
tured for 48 h with the indicated combinations of RIC and 32P-labeled STAS
RNA, then mitochondria were isolated and mtRNA analyzed by autoradiog-
raphy. CYB, apocytochrome b; COI, COII, cytochrome oxidase subunits I
and II; A6, F1Fo ATP synthase subunit 6. (C) Left, import of 32P-labeled
STAS RNA–DNA chimera [STAS(ND1DNA] into isolated mitochondria in
the presence or absence of RIC and ATP. Right, RIC-dependent uptake of
32P-labeled STAS chimera by HepG2 cells in the presence or absence of
RIC and their localization in the mitochondrial (M) or cytosolic (C) fraction.
The recovered RNA was treated with DNase or RNase and rerun in parallel.
The labeled RNAse-resistant fragment is the in vitro synthesized oligomer
primed by D arm RNA of low specific activity. (D) Confocal images of live
HepG2 cells treated with RIC and Alexa Fluor-labeled STAS(ND1) RNA
(green) for the indicated times. Cells were counterstained with Mitotracker
Deep Red 633 (red). Bar, 15 mm. (E) Dependence of STAS uptake on
import signal and RIC. Indicated RNAs were incubated with HepG2 cells
for 24 h in the presence (top and middle) or absence (bottom) of RIC. (F)
Higher magnification of a Hep G2 cell treated with STAS(ND1). Bar, 6.9 mm.
Figure 2. Fate of STAS-targeted mitochondrial mRNAs. (A) Northern blots of
mitochondrial RNA from Hep G2 cells treated for 48 h with the STAS RNAs
indicated at the top, probed with oligonucleotides complementary to the mt
genes indicated next to each band. In the leftward three panels, the blot was
sequentially hybridized with the probes indicated. Sizes (kb) of the respective
mRNAs (27) are indicated. (B and C) Effect of STAS-target mismatch (B) and
position (C) on ND1 mRNA. HepG2 cells were treated with the indicated
RNAs and mitochondrial ND1, or cytosolic b-actin, mRNA probed after
48 h. D, D arm RNA; STAS(ND1-0,1,2,3), signal-tagged RNA with 0–3 mis-
matches with target (Fig. 1A); DNA, signal-tagged anti-ND1 oligodeoxyribo-
nucleotide; starting positions of ND1 mRNA targeted are indicated below
panel C. (D) Time-dependent degradation of STAS-targeted ND1 mRNA.
Northern blots of mt mRNA from Hep G2 cells treated with STAS(ND1)-RIC
for the indicated times. Probes: top, ND1 50 (antisense); middle, ND1 30 (anti-
sense); bottom, ND1 5’ (sense). Positions of the probes on the mRNA map,
and degradation pause sites (arrows), are shown at the top. (E) Dose-
dependence of STAS-induced target degradation. Cells were treated with the
indicated concentrations of STAS(ND1) plus RIC for 12 h.
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by northern blotting. Essentially complete mitochondrial
uptake of STAS(ND1) RNA occurred rapidly, between 1
and 3 h; the imported RNA persisted at peak level for at
least 72 h (Fig. 2D). The kinetic data confirm the microscopic
uptake studies showing mitochondrial targeting within 3 h of
treatment (Fig. 1). Moreover, they indicate the high stability
(half-life in excess of 3d) of the internalized STAS.
The level of the target mRNA was unchanged up to 3 h;
from 6 h onwards, a series of partial degradation products
appeared, leading to the complete disappearance of hybridiz-
able mRNA by 48 h (Fig. 2D). In this experiment, the probe
hybridizing with the degradation products is complementary
to the 5’ terminal sequence of the target; in contrast, only
the full-length mRNA hybridized with an oligonucleotide
complementary to the 30-end of the coding region (Fig. 2D).
Thus the partial products represent pause sites of the degra-
dation machinery at various distances from the 5’ end.
The effect of STAS dosage on its biological effect (target
degradation) on cultured cells was studied. In 12 h-treated
cells, degradation of the target was evident between 2.5 and
5 nM STAS (Fig. 2E). A further increase in STAS concen-
tration in the culture medium did not lead to enhancement
of degradation rate, since identical degradation patterns were
observed between 5 and 20 nM (Fig. 2E). Thus, target sites
are saturated within 5 nM STAS, with excess antisense
RNA having no effect on degradation rate.
STAS-mediated inhibition of cellular respiration
The downstream effects of STAS-induced downregulation of
mitochondrial mRNAs on cellular respiratory functions were
examined. In mitochondria from STAS-treated cells, synthesis
of the targeted protein was specifically reduced, with no sig-
nificant effect on the rest of the mitochondrial proteome
(Fig. 3A). Significant downregulation occurred with all the
antisense RNAs tested, although the extent of inhibition was
somewhat variable after 48 h of treatment, with marked
effects with a few, e.g. anti-CYB and anti-ND1. In all cases,
the translation initiation region was targeted; thus, the variabil-
ity may be a result of structural features of the mRNAs that
preclude or enhance binding of the antisense RNA.
To test whether the observed downregulation of target
protein synthesis was sufficient to inactivate the corresponding
respiratory complex, activity assays of these complexes in
inner membrane extracts, or in situ, were performed. In
STAS(ND1)-treated cells, the activity of NADH dehydrogen-
ase (complex I) was reduced by more than 80%; in the same
cells, the activities of other respiratory complexes were unaf-
fected (Fig. 3B; Supplementary Material, Tables S2–S4).
Similarly, complex III activity was undetectable, but
complex I activity normal, in the presence of STAS(CYB),
while cytochrome c oxidase activity was specifically affected
in cells treated with anti-COI (Supplementary Material, Tables
S2–S4).
Thus the path of electrons from respiratory substrates to
molecular O2 could be blocked at different steps of the elec-
tron transport chain. This was reflected in a 4-fold reduction
in O2 uptake by cells targeted at ND1 (complex I), CYB
(complex III) and COI (complex IV) (Fig. 3C). Neither RIC
alone, nor the import signal in the presence of RIC, affected
respiration (Fig. 3C). In parallel, the uptake of rhodamine
123, a membrane potential-sensitive dye that is concentrated
by actively respiring mitochondria (17), was significantly
reduced (Fig. 3D). The quantified rhodamine 123 fluorescence
in individual cells was lowered by 70% from 75.2+ 5.2
(n ¼ 50) to 22.7+ 6.2 (n ¼ 50) arbitrary units/cell for
untreated and STAS(ND1)-treated HepG2, respectively. A
similar reduction [to 28.0+ 2.6 (n ¼ 17) units/cell], but not
elimination, of rhodamine 123 uptake was also observed in
the cybrid FLP32.39, containing a mitochondrial deletion of
four genes including those encoding two cytochrome c
Figure 3. Biochemical and physiological effects of STAS RNA. (A) Synthesis
of 35S-methionine-labeled proteins in mitochondria from Hep G2 cells treated
with RIC and the indicated RNAs. Individual downregulated proteins are indi-
cated by arrowheads. Mitochondrion-encoded protein bands identified at the
left. (B) Mitochondrial NADH dehydrogenase (complex I) activity (black
bars) in Hep G2 cells treated with the indicated RNAs for 2d. The same mito-
chondrial extracts were assayed for complex III (hatched bars), and the cells
stained for cytochrome c oxidase (complex IV; stippled bars). (C) Oxygen
uptake in 48 h STAS-RIC treated Hep G2 cells. Additions to the culture
were as indicated. In (B) and (C), activities are expressed as percent
maximum. Mean values and standard deviations are shown in Supplementary
Material, Tables S2–S5. (D) Hep G2 cells were treated with RIC, along with
D arm RNA (upper) or STAS(ND1) (lower) for 48 h, and live cells were
stained with rhodamine 123. Bar, 30 mm. (E) Growth of Hep G2 cells
treated with RIC and D arm RNA (circles) or STAS(ND1) (squares) in
glucose-deficient DMEM medium supplemented with glucose (open
symbols) or galactose (filled symbols).
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oxidase subunits (18). The residual membrane potential in
these respiration-deficient cells is probably created by
complex V-mediated hydrolysis of glycolytically generated
ATP. The lowering of the membrane potential is due to inhi-
bition of the transmembrane proton gradient, the formation of
which is coupled to electron transport. Inhibition of ATP syn-
thesis by antisense-mediated downregulation of subunit A6/A8
(both subunits are translated from the same mRNA), also
resulted in inhibition of O2 uptake by 85% (Fig. 3C); this
reflects the two-way coupling between the proton gradient
and ATP synthesis in these antisense-transformed mitochon-
dria. In cybrids homoplasmic for a mutation in the A6 gene,
as well as normal cells treated with oligomycin (a complex
V inhibitor), the inhibition of O2 uptake is more moderate,
about 50–60% (19). The similar extents of acute inhibition
of respiration (85%) in all the antisense transformants
could be due to a generalized damage of respiratory com-
plexes, e.g. by accumulation of Reactive Oxygen Species
(ROS), which has been shown to occur in the A6 mutant
cybrids (19).
In spite of the respiratory deficiency, mitochondrial
antisense-transformed cells grew normally in glucose-
containing media, presumably depending upon glycolysis to
generate ATP (Fig. 3E). Failure to utilize galactose is a
characteristic of respiration-deficient cells (20). In normal,
glucose-containing medium, STAS(ND1) had no appreciable
effect on the growth or morphology of the hepatocarcinoma
(Hep G2) cells; however, in the presence of galactose,
STAS(ND1)-treated HepG2 cells were unable to grow
(Fig. 2E).
DISCUSSION
In this report we show that the protozoal RNA transporter RIC
delivers signal-tagged exogenous small RNA or DNA into
mitochondria of cultured human cells. Delivery is highly effi-
cient: RNA is transferred to most or all of the mitochondria in
more than 80% of the cells within 3 h of treatment (Fig. 1).
The imported RNA is stable, with a half-life of greater than
3d (Fig. 2). Moreover, antisense sequences appended to the
tag induce specific and quantitative degradation of the corre-
sponding mRNA (Fig. 2). This procedure requires the appli-
cation of nanomolar quantities of RNA, is generally
applicable to multiple mitochondrial mRNAs and produces
predictable effects on cellular respiration. It will be pertinent
here to compare this delivery method to existing methods of
gene transfer.
Among the existing physical, chemical and biological
methods of gene transfer, the one with the closest similarity
to the complex-mediated transfer described here uses viral
vectors (21). Both viruses and RIC deliver DNA or RNA
with high efficiency to intact cells. Most viruses are taken
up endocytotically, utilizing specific cell-surface receptors;
RIC is similarly internalized by a caveolin-dependent, presum-
ably endocytotic pathway (13). However, whereas the viral
genome is targeted to the nucleus or retained in the cytosol,
signal-tagged nucleic acids are targeted to mitochondria by
RIC. The exploitation of cell surface receptors and intracellu-
lar trafficking pathways accounts for the high efficiency of
both viral and RIC-mediated gene transfer. Viral capsids
enclose and protect the genomic cargo, and can deliver
several kilobases of DNA/RNA; in contrast, the ability of
RIC to carry small RNA oligonucleotides has been demon-
strated, and the cargo is bound to the protein complex but
may be significantly exposed to the medium. The rapid
uptake of RIC-bound RNA may minimize extracellular degra-
dation; inside the organelle, the RNA is remarkably stable,
most likely due to the presence of the D arm hairpin at the
5’ end.
Antisense Oligonucleotides (ASO) and double-stranded
small interfering (si) RNAs have been employed to target cel-
lular and viral mRNAs in vivo, and some are under clinical
trial or have been approved for therapeutic application (22).
Current protocols use chemically modified oligonucleotides
for enhanced stability and targeting specificity. However, the
uptake mechanism is unknown, and delivery is slow and inef-
ficient, requiring high concentrations (.100 nM) of ASO.
Moreover, short hairpin RNAs, which generate siRNAs intra-
cellularly, have been reported to have in vivo toxicity (23). In
contrast, RIC delivers unmodified RNA rapidly and efficiently
to the targeted compartment. RIC is known not to have any
significant cytotoxic effects on cultured cells (13), but the effi-
cacy and toxicity of RIC-mediated procedures in animal
models are yet to be evaluated.
A number of approaches to deliver nucleic acids to mito-
chondria have been reported. Oligonucleotides coupled to a
mitochondrial targeting peptide (9) and PNAs conjugated
with lipophilic cations (10) are technically demanding and
expensive to prepare, in comparison to the use of simple
unmodified RNA/DNA in the RIC method. Moreover, the pro-
blems of targeting efficiency and biological efficacy associated
with these approaches are largely absent in the current pro-
cedure.
Not much is known about post-transcriptional regulatory
mechanisms in mitochondria (24). Our experiments reveal
for the first time the existence of a mitochondrial pathway
for small RNA-mediated degradation of mRNA. Degradation
is target-specific, presumably signaled by the pairing of the
antisense with its target site, but the efficiency may vary
between targets or between different sites within the same
mRNA. In prokaryotes (from whose ancestors mitochondria
were presumably derived), a number of small RNAs regulate
target mRNAs post-transcriptionally under stress conditions
(25). In these systems, mRNA degradation involves the
degradosome, a complex of proteins including an RNA heli-
case, an RNase III-type endonuclease and an exonuclease
(25). Yeast mitochondria contain a similar complex (26),
and mammalian mitochondria contain a helicase (Suv3p)
(27) and an exonuclease (polynucleotide phophorylase)
(28). The roles of these proteins in antisense-mediated
mRNA degradation remain to be elucidated. Interestingly,
human Suv3p acts on both RNA:RNA and RNA:DNA
duplexes (27); the degradative effect of tagged RNA or
DNA (Fig. 2) may be the reflection of the involvement of
this protein. It will be important to determine whether the
degradosome is involved in antisense-mediated mRNA
degradation, and whether this mechanism has any physio-
logical significance in terms of regulating mitochondrial
function.
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MATERIALS AND METHODS
Cell culture
The human hepatocarcinoma cell line HepG2 was cultured as
monolayers in DMEM medium containing 4.5 g/l glucose,
110 mg/l sodium pyruvate and 10% fetal bovine serum
(FBS). Growth of HepG2 cells was monitored on glucose-
deficient DMEM supplemented with 0.9 mg/ml of glucose or
galactose.
Preparation of signal-tagged RNAs
Signal-tagged antisense (STAS) RNAs consisted of a 50
domain containing the D arm hairpin from L. tropica and a
30domain complementary to a specific targeted mitochondrial
mRNA (Supplementary Material, Table S6). Target design
was based on the published human mitochondrial genome
sequence (29). Appropriate oligonucleotide templates were
prepared and transcribed with T7 RNA polymerase (Sup-
plementary Materials). To prepare fluorescent RNA, the tran-
scription reaction contained, additionally, 0.5 nmol of 5-Alexa
Fluor 488-UTP (Molecular Probes).
Preparation of signal-tagged DNA
D arm RNA was synthesized as described (30), and 10 pmol
was annealed to 50 pmol of the anti-ND1 oligonucleotide
O-284 (Supplementary Material, Table S6). The RNA
primer was extended with Klenow enzyme in the presence
of the four dNTPs including [a-32P] TTP, to yield the
RNA–DNA chimera which was melted off and gel-purified.
The product was further confirmed to be the expected
RNA–DNA adduct by treating one fraction with RNase A
plus T1 for 15 min at 378C and another with 1.5 units of
DNase I for 20 min on ice, and running the digests on a 6%
denaturing PAGE.
Purification of RIC
RIC was purified from inner membrane extracts of L. tropica
by RNA affinity chromatography (12).
Mitochondrial import assay
HepG2 mitochondria (100 mg protein), isolated as described
(31), were pre-incubated for 1 h on ice with RIC (200 ng),
then incubated with 2.5 nM of 32P-labeled RNA in import
buffer in the presence of 4 mM ATP at 378C for 15 min,
and RNase-resistant imported RNA analyzed by gel electro-
phoresis (14).
Treatment of cells with antisense RNA
RNA and RIC (200 ng) were pre-incubated in 20 ml of buffer
BB (10 mM Tris–HCl, pH 7.5, 10 mM MgCl2, 1 mM DTT) for
30 min at 48C, to allow complex formation. The mixture was
then directly applied to1 ml medium over HepG2 mono-
layers in 40-mm diameter Petri dishes and the cells cultured
for the indicated times before harvesting.
Northern analysis
Mitochondria were isolated from lysates of STAS-treated cells
by differential centrifugation, and treated with 2.5 mg/ml of
RNase A and 50 units/ml of RNase T1 for 15 min at 378C.
RNA was prepared by guanidinium isothocyanate extraction
and run on 1% agarose-formaldehyde gels in 0.2 M MOPS,
50 mM sodium acetate, 1 mM EDTA, transferred to Hybond
Nþ membrane (Amersham-GE) by semi-dry transfer, and
UV-crosslinked to the membrane. Blots were pre-hybridized
for 4–6 h at 508C in OH buffer: 5XNET (0.5 M NaCl,
0.1 M Tris–HCl, pH 7.5, 5 mM EDTA), 5X Denhardt’s sol-
ution (0.5% bovine serum albumin, 0.5% Ficoll, 0.5% polyvi-
nyl pyrrolidone), 20 mM sodium phosphate, 0.1% SDS and
200 mg/ml denatured calf thymus DNA. The filters were
hybridized at 508C overnight with 50 –32P labeled oligonucleo-
tide probe (105–106 cpm/ml) in buffer OH. Blots were given
stringency washes: 6XSSC, 0.1% SDS, room temperature,
thrice; and 6XSSC, 0.1% SDS, 658C, once. Washed mem-
branes were autoradiographed. In some cases, a blot was
sequentially hybridized with two probes without an interven-
ing melt-off step, so that mRNAs of different sizes could be
simultaneously visualized.
Assays of mitochondrial function
In organello translation, respiratory complex activity and O2
uptake assays were performed as described (Supplementary
Material).
Live cell imaging
HepG2 monolayers were harvested, washed with PBS-glucose
at 48C, and allowed to adhere to polylysine-coated slides.
Adhered cells were overlayed with staining solution, and
after 5–15 min, were observed under a Leica DMIRB confo-
cal microscope. Staining solutions contained PBS-glucose and
Mitotracker Deep Red (1 mM) or Rhodamine 123 (0.2 mg/ml).
Illumination laser wavelengths were 488 nm (Alexa Fluor 488
and Rhodamine 123) and 633 nm (Mitotraker Deep Red).
Control and experimental specimens were scanned and ana-
lyzed under identical gain and other settings. Image capture,
processing and quantification of fluorescence were carried
out using Leica SP2 confocal software.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
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